You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Prolonged apnea may occur in patients with a genetically determined abnormal variant of cholinesterase following intravenous administration of and explain in detail?
Both succinylcholine and mivacurium are completely and rapidly eliminated by plasma cholinesterase. Other nondepolarizing neuromuscular blockers, such as tubocurarine, pancuronium, and atracurium, are eliminated by renal or hepatic mechanisms or by spontaneous hydrolysis (atracurium). Patients with genetically determined atypical cholinesterase may be detected by measuring the inhibition of cholinesterase by dibucaine, a local anesthetic. Dibucaine inhibits the normal enzyme about 80%, but the abnormal variant is inhibited only 20%.